Markus Schuler

8PUBLICATIONS
21CO-AUTHORS
Natural language processingPharmacogenomicsPredictive and prognostic markersDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 02, 2025
Enabling Just-in-Time Clinical Oncology Analysis With Large Language Models: Feasibility and Validation Study Using Unstructured Synthetic Data.

Peter May, Julian Greß, Christoph Seidel

|Jun 19, 2024
Medication Risks and Their Association with Patient-Reported Outcomes in Inpatients with Cancer.

Maximilian Günther, Markus Schuler, Leopold Hentschel

|Feb 10, 2024
Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13).

Bernd Kasper, Daniel Pink, Christian Rothermundt

|Feb 25, 2023
Electronic Patient Reported Outcome (ePRO) Measures in Patients with Soft Tissue Sarcoma (STS) Receiving Palliative Treatment.

Silvia Hofer, Leopold Hentschel, Stephan Richter

|Feb 11, 2023
Management of Locally Advanced or Metastatic Combined Hepatocellular Cholangiocarcinoma.

Jemmy Zhao, Susann Stephan-Falkenau, Markus Schuler

|Jan 13, 2021
Reply to E. Younger et al, V. Sharma et al, and M. Uchihara et al.

Viktor Grünwald, Xiaofei Liu, Markus Schuler

Pageof 2

Frequent Collaborators

3 joint publications

Bernd Kasper

2 joint publications

Daniel Pink

1 joint publications

Leopold Hentschel

1 joint publications

Ivan Platzek